Martín Rosas-Peralta

ORCID: 0000-0001-8084-8981
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Health and Lifestyle Studies
  • Blood Pressure and Hypertension Studies
  • Acute Myocardial Infarction Research
  • Cardiac Health and Mental Health
  • Sodium Intake and Health
  • Global Public Health Policies and Epidemiology
  • Obesity, Physical Activity, Diet
  • Birth, Development, and Health
  • Nutritional Studies and Diet
  • Cardiovascular Function and Risk Factors
  • Diabetes, Cardiovascular Risks, and Lipoproteins
  • Cardiac, Anesthesia and Surgical Outcomes
  • Consumer Attitudes and Food Labeling
  • Cardiac Arrest and Resuscitation
  • Hormonal Regulation and Hypertension
  • Pulmonary Hypertension Research and Treatments
  • Heart Rate Variability and Autonomic Control
  • Health and Medical Education
  • Heart Failure Treatment and Management
  • Public Health and Social Inequalities
  • Healthcare Systems and Reforms
  • Aortic Disease and Treatment Approaches
  • Cardiac Structural Anomalies and Repair
  • Food, Nutrition, and Cultural Practices
  • Congenital Heart Disease Studies

Instituto Nacional de Cardiologia
2004-2025

Asociación Colombiana de Nefrología e Hipertensión Arterial
2023-2024

Academia Nacional de Medicina
2024

Mexican Social Security Institute
2015-2023

Instituto de Salud del Estado de México
2023

American Heart Association
2019

American College of Cardiology
2019

Centro Medico Nacional Siglo XXI
2015-2018

Instituto Nacional de Cardiología
1998-2016

The Expert Committee in charge of developing the Beverage Consumption Recommendations for Mexican Population was convened by Secretary Health purpose evidence-based guidelines consumers, health professionals, and government officials. prevalence overweight, obesity diabetes have dramatically increased Mexico; beverages contribute a fifth all calories consumed Mexicans. Extensive research has found that caloric increase risk obesity. Taking into consideration multiple factors, including...

10.1590/s0036-36342008000200011 article EN cc-by-nc-sa Salud Pública de México 2008-03-26

Abstract BACKGROUND Arterial hypertension is a significant cause of morbidity and mortality in Mexico. However, there limited evidence to understand blood pressure management cardiometabolic profiles. Here, we aim assess the prevalence controlled uncontrolled pressure, as well risk factors among patients from Mexican Registry Hypertension (RIHTA). METHODS We conducted cross-sectional analysis participants living with arterial registered on RIHTA between December 2021 April 2023. used both...

10.1093/ajh/hpae024 article EN cc-by American Journal of Hypertension 2024-03-11

Abstract Discrimination in cardiovascular healthcare, particularly concerning hypertension treatment, is a significant and complex issue Latin America, driven by biases related to gender, ethnicity, economic status. Although disease (CVD) the leading cause of death worldwide, disparities healthcare delivery endure, especially impacting marginalized populations. Women, ethnic minorities, economically disadvantaged groups encounter considerable barriers, including underrepresentation clinical...

10.1093/ajh/hpaf050 article EN cc-by American Journal of Hypertension 2025-03-31

hypertension and dyslipidemia share common pathophysiological mechanisms, such as obesity the resulting dysregulation of adipokine release.Dyslipidemia, however, adversely affects functional structural arterial characteristics promotes atherosclerosis.These changes may affect BP regulation, which, in turn, predisposes people with to development hypertension. 10,11rom an epidemiological perspective, several cohort studies have indicated a causal relationship between future risk developing...

10.35366/115053 article EN Cardiovascular and Metabolic Science 2024-01-01

<p style="text-align:justify"><strong>Introducci&oacute;n: </strong>M&eacute;xico tiene la mortalidad m&aacute;s alta a 30 d&iacute;as por infarto agudo de miocardio (IAM), el cual constituye una las principales causas en pa&iacute;s: 28 % versus 7.5 del promedio los pa&iacute;ses Organizaci&oacute;n para Cooperaci&oacute;n y Desarrollo Econ&oacute;micos. <strong>Objetivo: </strong>Establecer rutas cr&iacute;ticas estrategias farmacol&oacute;gicas esenciales interinstitucionales...

10.24875/gmm.m21000455 article ES cc-by-nc-nd Gaceta Médica de México 2021-03-31
Coming Soon ...